Arcturus Therapeutics Holdings (ARCT) Other Non-Current Liabilities (2021 - 2023)

Arcturus Therapeutics Holdings' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $497000.0 for Q4 2023.

• Quarterly Other Non-Current Liabilities fell 82.28% year-over-year to $497000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $497000.0 (down 82.28% YoY) and the FY2023 annual result came in at $497000.0, down 82.28% from the prior year.
• Other Non-Current Liabilities was $497000.0 for Q4 2023 at Arcturus Therapeutics Holdings, down from $976000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $3.7 million in Q3 2022 and bottomed at $358000.0 in Q1 2021.
• A 3-year average of $1.5 million and a median of $1.3 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 163.7% — and 2023, when it plunged 82.28%.
• Arcturus Therapeutics Holdings' Other Non-Current Liabilities stood at $1.4 million in 2021, then jumped by 101.15% to $2.8 million in 2022, then plunged by 82.28% to $497000.0 in 2023.
• Business Quant data shows ARCT's Other Non-Current Liabilities at $497000.0 in Q4 2023, $976000.0 in Q3 2023, and $1.3 million in Q2 2023.